Company news
OpSens Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
OpSens Announces FIRST Quarter fiscal 2022 Financial Results
January 13, 2022
OpSens to host first quarter fiscal year 2022 financial results conference call on Thursday, January 13, 2022
January 6, 2022
OpSens announces 510(k) submission to U.S. FDA for new guidewire for the TAVR procedure
December 13, 2021
Opsens to Present at the Lytham Partners Winter 2021 Investor Conference: Presentation at 11 Am (ET), Monday December 13, 2021
December 7, 2021
OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results
November 23, 2021
OpSens Successfully Completes 20-Patient in Human Clinical Study for TAVR Procedure
November 23, 2021
OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021
November 17, 2021
OpSens will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genuity MedTech & Diagnostics Forum
November 10, 2021
OPSENS' SAVVYWIRE(TM) Featured at the Transcatheter Cardiovascular Therapeutics 2021 Annual Meeting in Orlando
November 8, 2021
OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure
October 13, 2021
OpSens to Present at the Lytham Partners Fall 2021 Investor Conference
September 29, 2021
OPSENS Receives Approval from Health Canada to Initiate First In-Man Clinical Study for its New Guidewire for the TAVR Procedure
September 20, 2021
OpSens Appoints Lori Chmura to its Board of Directors
September 8, 2021
OpSens Announces Third Quarter Fiscal 2021 Record Financial Results
July 13, 2021
OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13, 2021
July 7, 2021
OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts
June 16, 2021
OpSens will Participate and Present at two Investment Conferences - Lytham Partners and Raymond James
June 9, 2021
OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
May 13, 2021
OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain
April 21, 2021
OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues
April 14, 2021
OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III
April 7, 2021
OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021
April 6, 2021
OpSens to Present at Lytham Partners Spring 2021 Investor Conference
March 22, 2021
OpSens Announces Closing of $28.75 Million Bought Deal Public Offering Including $3.75 Million Over-Allotment Option Exercised in Full
February 25, 2021
OpSens Obtains CE Marking for the OptoWire III
February 18, 2021
OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)
February 8, 2021
OpSens Inc. Announces $25 Million Bought Deal Offering
February 5, 2021
OpSens Announces First Quarter Fiscal 2021 Financial Results
January 13, 2021
OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021
January 6, 2021
OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 24, 2020
OpSens Announces Fourth Quarter and Fiscal Year 2020 Financial Results
November 19, 2020
OpSens Recognized as One of the Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500(TM)
November 18, 2020
OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020
November 12, 2020
OpSens to Present at the Virtual Fall Investor Summit on November 16
November 12, 2020
OpSens Awarded Contract by Major U.S. Group Purchasing Organization
October 14, 2020
OpSens to Present at Lytham Partners Virtual Investor Growth Conference
September 30, 2020
OpSens to Present at the LD 500 Virtual Conference
August 26, 2020
LD Micro Announces Preliminary List of Presenters for the LD-500
August 5, 2020
OpSens Announces Result for Q3 2020
July 15, 2020
OpSens - 100,000 Cases Performed with the OptoWire
May 20, 2020
OpSens Announces Q2 2020 Results
April 9, 2020
OpSens provides operational update - OpSens continues to supply essential cardiovascular solutions to patients around the world
March 24, 2020
Opsens - Election Results for the Board of Directors
January 22, 2020
Opsens Receives FDA Approval of Optowire III
January 13, 2020
Opsens - Announces Q1 2020 Results
January 13, 2020
Opsens Receives dPR Clearance from the FDA
December 19, 2019
Opsens - Record FY2019 Consolidated Revenues of $32.8 M, Up 36%, Record FFR Revenues of $20M, Up 41%
November 14, 2019
Opsens Announces Entry Into Structural Heart Market
November 5, 2019
Opsens Solutions - Strategic Order for Fiber Optic Sensors to be Deployed in New Industrial Dewatering Process
July 16, 2019
Opsens - Q3 2019 - Record Quarterly FFR Revenues of $5.2 M, Up 49%
July 11, 2019
Decks
The 5 newest of 12 decks. Every deck is listed under its year.
- Investor Presentation (November 2023)
Investor deck · 48 slides · Nov 22, 2023
- Investor Presentation (July 2023)
Investor deck · 48 slides · Jul 31, 2023
- Investor Presentation (July 2023)
Investor deck · 44 slides · Jul 31, 2023
- Investor Presentation (May 2023)
Investor deck · 48 slides · May 31, 2023
- Investor Presentation (2023)
Investor deck · 44 slides · Mar 1, 2023